In 2023, Yuhan Corporation posted the largest revenue among pharmaceutical companies in South Korea, at around 1.86 trillion South Korean won. The company focuses on the production of ingredients for medications as well as finished medications across various medical fields. Other leading companies included Chong Kun Dang and GC Pharma.
COVID-19 and Korean pharmaceuticals
The global coronavirus pandemic affected Korean pharmaceutical companies badly. Most of them suffered from decreased revenues and losses because of poor overseas results from the pandemic, a drop in prescriptions as people avoided hospitals, ongoing legal challenges, and more. A few South Korean pharmaceutical companies enjoyed increased revenues in 2020 and 2021, including Yuhan Corporation. Chong Kun Dang has been developing its own coronavirus (COVID-19) treatment, which won domestic and overseas approval for drug trials in 2021. Meanwhile, GC Pharma is involved in the development of vaccines and treatments for cancer and infectious diseases. Pharmaceutical drugs related to cancer see high usage rates, and development in the field of infectious diseases has naturally surged during the pandemic, helping the company increase their revenue.
Pharmaceutical producers in Korea
Leading Korean pharmaceutical producers include Celltrion, Hanmi Pharmaceutical, and Chong Kun Dang. Moderna Korea was the leading company by production value in 2022. Many producers saw increases in sales during the pandemic due to being involved in the production of several medical products related to COVID-19, most notably testing kits, Celltrion's sales revenue increased substantially in 2020 and 2021.
Leading pharmaceutical companies in South Korea in 2023, by revenue
(in billion South Korean won)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Medifonews. (March 18, 2024). Leading pharmaceutical companies in South Korea in 2023, by revenue (in billion South Korean won) [Graph]. In Statista. Retrieved December 09, 2024, from https://www.statista.com/statistics/1072681/south-korea-leading-pharmaceutical-companies-by-revenue/
Medifonews. "Leading pharmaceutical companies in South Korea in 2023, by revenue (in billion South Korean won)." Chart. March 18, 2024. Statista. Accessed December 09, 2024. https://www.statista.com/statistics/1072681/south-korea-leading-pharmaceutical-companies-by-revenue/
Medifonews. (2024). Leading pharmaceutical companies in South Korea in 2023, by revenue (in billion South Korean won). Statista. Statista Inc.. Accessed: December 09, 2024. https://www.statista.com/statistics/1072681/south-korea-leading-pharmaceutical-companies-by-revenue/
Medifonews. "Leading Pharmaceutical Companies in South Korea in 2023, by Revenue (in Billion South Korean Won)." Statista, Statista Inc., 18 Mar 2024, https://www.statista.com/statistics/1072681/south-korea-leading-pharmaceutical-companies-by-revenue/
Medifonews, Leading pharmaceutical companies in South Korea in 2023, by revenue (in billion South Korean won) Statista, https://www.statista.com/statistics/1072681/south-korea-leading-pharmaceutical-companies-by-revenue/ (last visited December 09, 2024)
Leading pharmaceutical companies in South Korea in 2023, by revenue (in billion South Korean won) [Graph], Medifonews, March 18, 2024. [Online]. Available: https://www.statista.com/statistics/1072681/south-korea-leading-pharmaceutical-companies-by-revenue/